Indication
Mixed
5 clinical trials
6 products
1 drug
Product
NUV-422Clinical trial
Phase 1/2 Dose Escalation, Safety, Pharmacokinetics, and Efficacy Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid TumorsStatus: Terminated, Estimated PCD: 2022-08-31
Clinical trial
Pilot Randomized Neo-adjuvant Evaluation of Poly-ICLC-Assisted Tumor Lysate Vaccines in Adult Patients With WHO Grade II GliomaStatus: Active (not recruiting), Estimated PCD: 2022-08-15
Product
GBM6-ADClinical trial
Hyperpolarized Carbon-13 Alpha-ketoglutarate Metabolic Imaging in IDH Mutant GliomaStatus: Recruiting, Estimated PCD: 2026-04-30
Clinical trial
Clinical Trial to Determine the Effects of Statins on Brain Health - STAREE-Mind Imaging SubstudyStatus: Active (not recruiting), Estimated PCD: 2026-09-01
Product
AtorvastatinDrug
VarlilumabClinical trial
Pilot Randomized Neo-adjuvant Evaluation of Agonist Anti-CD27 Monoclonal Antibody Varlilumab on Immunologic Activities of IMA950 Vaccine Plus Poly-ICLC in Patients With WHO Grade II Low-Grade Glioma (LGG)Status: Active (not recruiting), Estimated PCD: 2022-12-31
Product
IMA950Product
poly-ICLC